LEARNING OBJECTIVES:
Upon completion of this activity, participants should be able to:
- Identify key characteristics of COVID-19 pathophysiology that are associated with more progressive and severe disease
- Summarize efficacy and safety of treatments that are recommended to treat hospitalized patients with severe COVID-19
- Make immunomodulatory treatment decisions (eg, agent selection and timing of initiation) for hospitalized patients with severe COVID-19 based on clinical characteristics and current data